Richards Steven M's Form 4 filing
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) · filed Jan 9, 2023
- Accession no.
- 0001493152-23-000941
- Filed
- Jan 9, 2023
- Trade date
- Dec 29, 2022
- Filing delay
- 11 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $1.60K. It was filed 11 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Richards Steven MCIK 0001945980 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2022 | COMMON STOCK | SSaleDisposed | −995 | $1.61 | −$1,601.95 | 1,707 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.